1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. GeneCentric Therapeutics Acquires Select ImmunoGenomics

M&A Deal Summary

GeneCentric Therapeutics Acquires Select ImmunoGenomics

On August 15, 2019, GeneCentric Therapeutics acquired information technology company Select ImmunoGenomics

Acquisition Highlights
  • This is GeneCentric Therapeutics’ 1st transaction in the Information Technology sector.
  • This is GeneCentric Therapeutics’ 1st transaction in the United States.
  • This is GeneCentric Therapeutics’ 1st transaction in North Carolina.

M&A Deal Summary
Date 2019-08-15
Target Select ImmunoGenomics
Sector Information Technology
Buyer(s) GeneCentric Therapeutics
Deal Type Add-on Acquisition

Target

Select ImmunoGenomics

Apex, North Carolina, United States
Select ImmunoGenomics, Inc. is a provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs. Select ImmunoGenomics is based in Apex, North Carolina.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

GeneCentric Therapeutics

Durham, North Carolina, United States
Category Company
Sector Information Technology
DESCRIPTION

GeneCentric Therapeutics, Inc. is a genomic solutions provider. The company’s technologies are designed to parse the complexity of tumor biology and generate signatures to responder populations to oncology drugs. GeneCentric Therapeutics is based in Durham, North Carolina.

DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal